These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 15908846)

  • 21. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.
    Pilon D; Alcusky M; Xiao Y; Thompson-Leduc P; Lafeuille MH; Lefebvre P; Benson C
    J Med Econ; 2018 Feb; 21(2):135-143. PubMed ID: 28895766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy benefits and the use of drugs by the chronically ill.
    Goldman DP; Joyce GF; Escarce JJ; Pace JE; Solomon MD; Laouri M; Landsman PB; Teutsch SM
    JAMA; 2004 May; 291(19):2344-50. PubMed ID: 15150206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Renin-Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort Study.
    Campbell PJ; Axon DR; Taylor AM; Pickering M; Black H; Warholak T; Chinthammit C
    J Am Heart Assoc; 2020 Sep; 9(17):e016094. PubMed ID: 32844732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost and consequences of noncompliance to oral bisphosphonate treatment.
    Eisenberg DF; Placzek H; Gu T; Krishna A; Tulsi BB
    J Manag Care Spec Pharm; 2015 Jan; 21(1):56-65. PubMed ID: 25562773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events associated with prescription drug cost-sharing among poor and elderly persons.
    Tamblyn R; Laprise R; Hanley JA; Abrahamowicz M; Scott S; Mayo N; Hurley J; Grad R; Latimer E; Perreault R; McLeod P; Huang A; Larochelle P; Mallet L
    JAMA; 2001 Jan 24-31; 285(4):421-9. PubMed ID: 11242426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a patient-centered pharmacy program and intervention in a high-risk group.
    Moore JM; Shartle D; Faudskar L; Matlin OS; Brennan TA
    J Manag Care Pharm; 2013 Apr; 19(3):228-36. PubMed ID: 23537457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions.
    Jackson JE; Doescher MP; Saver BG; Fishman P
    Med Care; 2004 Nov; 42(11):1056-65. PubMed ID: 15586832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
    Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
    J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.
    Darkow T; Henk HJ; Thomas SK; Feng W; Baladi JF; Goldberg GA; Hatfield A; Cortes J
    Pharmacoeconomics; 2007; 25(6):481-96. PubMed ID: 17523753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs.
    Borah BJ; Huang X; Zarotsky V; Globe D
    Curr Med Res Opin; 2009 Jun; 25(6):1365-77. PubMed ID: 19425902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between medication supplies and healthcare costs in older adults from an urban healthcare system.
    Stroupe KT; Murray MD; Stump TE; Callahan CM
    J Am Geriatr Soc; 2000 Jul; 48(7):760-8. PubMed ID: 10894314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of cinacalcet adherence and costs in patients on dialysis.
    Lee A; Song X; Khan I; Belozeroff V; Goodman W; Fulcher N; Diakun D
    J Med Econ; 2011; 14(6):798-804. PubMed ID: 21988567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
    Jiang Y; Ni W
    Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between teriparatide adherence and healthcare utilization and costs among hip fracture patients in the United States.
    Zhao Y; Johnston SS; Smith DM; McMorrow D; Krege J; Krohn K
    Bone; 2014 Mar; 60():221-6. PubMed ID: 24361596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients.
    Zhao Y; Johnston SS; Smith DM; McMorrow D; Krohn K; Krege J
    Osteoporos Int; 2013 Sep; 24(9):2525-33. PubMed ID: 23529293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.